Evidence map›Paper›PMID 40553266›Full record

ReviewProtoplasma2025

Curdlan: a microbial biopolymer of multifarious applications for a sustainable environment.

Saumya Shukla, Kiran Vishwakarma, Anil Kumar Singh, Pradeep Kumar Yadav, Sudhir P Singh, Jyoti Singh Jadaun

Abstract readReview
PubMed Publisher
In one paragraph

Review in Protoplasma, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Saumya ShuklaDepartment of Botany, Dayanand Girls P.G. College, Kanpur Nagar, 208001, UP, India.
Kiran VishwakarmaDepartment of Botany, Dayanand Girls P.G. College, Kanpur Nagar, 208001, UP, India.
Anil Kumar SinghDepartment of Botany, Pt. Prithi Nath P.G. College, Kanpur, 208001, UP, India.
Pradeep Kumar YadavDepartment of Botany, Faculty of Science, University of Allahabad, Prayagraj, 211002, UP, India. pradeepiitkgp.yadav@gmail.com.
Sudhir P SinghDepartment of Industrial Biotechnology, Gujarat Biotechnology University, GIFT City, Gandhinagar, 382355, Gujarat, India. sudhir.singh@gbu.edu.in.
Jyoti Singh JadaunDepartment of Botany, Dayanand Girls P.G. College, Kanpur Nagar, 208001, UP, India. jsjdgpg2017@gmail.com.ORCID http://orcid.org/0000-0001-9276-4865

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Curdlan, an exopolysaccharide, has gained sufficient attention in recent years due to its potential health benefits. Its unique physico-chemical and rheological properties create an appropriate substitute for diverse applications in agriculture, food, and pharmaceutical industries. This review begins with an overview of bioactive properties, structural characteristics, curdlan biosynthesis, and its production technologies. Curdlan is useful in the modulation of immune responses and as an effective agent against diseases like malaria, cancer, dengue, and COVID-19. This review also expounds on the potential role of curdlan in the food industry as a thickener, texture modifier, stabilizer, and emulsifier. This biomolecule holds promise for functional food development due to its prebiotic properties. Research on curdlan has proved its potential role in the biomedical sector, and it acts positively in drug delivery and tissue engineering practices. Thus, curdlan offers a potential remedy in response to growing environmental concerns and the urgent demand for environment-friendly substitutes for synthetic polymers.

Indexed as

beta-GlucansBiopolymersHumansbeta-GlucansBiopolymerscurdlanAntimicrobialBiopolymerCOVID-19CurdlanExopolysaccharideGlycansPrebiotic

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.